Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy
Pharmacodynamic aggravation (PA) is an unpredictable increase in the frequency, the severity of existing seizures, and/or development of new seizure types despite rational (adequate for seizure type and epilepsy form) antiepileptic drug (AED) prescription. Many mechanisms and predictors of its devel...
Main Authors: | V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-08-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1629 |
Similar Items
-
Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults
by: T. N. Pushkar, et al.
Published: (2021-06-01) -
The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index
by: V. A. Karlov, et al.
Published: (2020-06-01) -
Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
by: V. A. Karlov, et al.
Published: (2020-11-01) -
Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
by: Barbara Miziak, et al.
Published: (2022-10-01) -
Modern possibilities of antiepileptic therapy at the start of treatment of focal epilepsy
by: P. N. Vlasov
Published: (2021-07-01)